Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaap Verweij

Showing results (61-70 of 234) with videos related to

Pageof 24
Sort By:
The Oncologist|December 7, 2007
The pharmacologic basis of ifosfamide use in adult patients with advanced soft tissue sarcomasMetin Tascilar, Walter J Loos, Caroline Seynaeve, et al.
Current Cancer Drug Targets|August 22, 2002
Pharmacology of topoisomerase I inhibitors irinotecan (CPT-11) and topotecanRon H J Mathijssen, Walter J Loos, Jaap Verweij, et al.
Anti-Cancer Drugs|June 5, 2003
Distribution of paclitaxel in plasma and cerebrospinal fluidHans Gelderblom, Sharyn D Baker, Ming Zhao, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 29, 2002
Determination of the docetaxel vehicle, polysorbate 80, in patient samples by liquid chromatography-tandem mass spectrometryAlex Sparreboom, Ming Zhao, Julie R Brahmer, et al.
Acta Oncologica (Stockholm, Sweden)|October 10, 2007
Irinotecan-induced central nervous system toxicity. Report on two cases and review of the literaturePaul Hamberg, Floris A De Jong, Dieta Brandsma, et al.
The Oncologist|August 2, 2006
Complementary and alternative medicine during cancer treatment: beyond innocenceMetin Tascilar, Floris A de Jong, Jaap Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2008
Lifestyle habits as a contributor to anti-cancer treatment failureFloris A de Jong, Alex Sparreboom, Jaap Verweij, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2004
Population pharmacokinetics of cisplatin in adult cancer patientsFelix E de Jongh, James M Gallo, Meiyu Shen, et al.
Analytical Biochemistry|April 15, 2004
Indirect determination of the irinotecan metabolite 7-ethyl-10-O-glucuronyl-camptothecin in human samplesPeter de Bruijn, Edwin W Willems, Walter J Loos, et al.
Clinical Pharmacology and Therapeutics|September 18, 2002
Clinical pharmacokinetics of irinotecan and its metabolites in relation with diarrheaRujia Xie, Ron H J Mathijssen, Alex Sparreboom, et al.
Pageof 24

Showing results (61-70 of 234) with videos related to

Sort By:
Pageof 24
The Oncologist|December 7, 2007
The pharmacologic basis of ifosfamide use in adult patients with advanced soft tissue sarcomasMetin Tascilar, Walter J Loos, Caroline Seynaeve, et al.
Current Cancer Drug Targets|August 22, 2002
Pharmacology of topoisomerase I inhibitors irinotecan (CPT-11) and topotecanRon H J Mathijssen, Walter J Loos, Jaap Verweij, et al.
Anti-Cancer Drugs|June 5, 2003
Distribution of paclitaxel in plasma and cerebrospinal fluidHans Gelderblom, Sharyn D Baker, Ming Zhao, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 29, 2002
Determination of the docetaxel vehicle, polysorbate 80, in patient samples by liquid chromatography-tandem mass spectrometryAlex Sparreboom, Ming Zhao, Julie R Brahmer, et al.
Acta Oncologica (Stockholm, Sweden)|October 10, 2007
Irinotecan-induced central nervous system toxicity. Report on two cases and review of the literaturePaul Hamberg, Floris A De Jong, Dieta Brandsma, et al.
The Oncologist|August 2, 2006
Complementary and alternative medicine during cancer treatment: beyond innocenceMetin Tascilar, Floris A de Jong, Jaap Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2008
Lifestyle habits as a contributor to anti-cancer treatment failureFloris A de Jong, Alex Sparreboom, Jaap Verweij, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2004
Population pharmacokinetics of cisplatin in adult cancer patientsFelix E de Jongh, James M Gallo, Meiyu Shen, et al.
Analytical Biochemistry|April 15, 2004
Indirect determination of the irinotecan metabolite 7-ethyl-10-O-glucuronyl-camptothecin in human samplesPeter de Bruijn, Edwin W Willems, Walter J Loos, et al.
Clinical Pharmacology and Therapeutics|September 18, 2002
Clinical pharmacokinetics of irinotecan and its metabolites in relation with diarrheaRujia Xie, Ron H J Mathijssen, Alex Sparreboom, et al.
Pageof 24